Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis (DOI:10.1016/j.cmet.2006.02.010);Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis

Cell Metabolism

Volumn 3, Issue 4, 2006, Pages 247-256

  Baumgartl, Julia ^a   Baudler, Stephanie ^a   Scherner, Maximilian ^b   Babaev, Vladimir ^c   Makowski, Liza ^d   Suttles, Jill ^e   McDuffie, Marcia ^f   Fazio, Sergio ^c   Kahn, C Ronald ^g   Hotamisligil, Gökhan S ^d   Krone, Wilhelm ^b   Linton, MacRae ^c   Brüning, Jens C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c VANDERBILT UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e University of Louisville School of Medicine   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BONE MARROW CELL; CELL LINEAGE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EMBRYO; HEPATOCYTE TRANSPLANTATION; INSULIN RESISTANCE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 33645563765     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2006.05.008     Document Type: Erratum

References (30)

1. S. Baudler J. Baumgartl B. Hampel T. Buch A. Waisman C.M. Snapper W. Krone J.C. Bruning Insulin-like growth factor-1 controls type 2 T cell-independent B cell response J. Immunol. 174 2005 5516-5525
2. S. Baudler W. Krone J.C. Bruning Genetic manipulation of the insulin signalling cascade in mice-potential insight into the pathomechanism of type 2 diabetes Best Pract. Res. Clin. Endocrinol. Metab. 17 2003 431-443
3. J.C. Bruning J.A. Gillette Y. Zhao C. Bjorbaeck J. Kotzka B. Knebel H. Avci B. Hanstein P. Lingohr D.E. Moller et. al. Ribosomal subunit kinase-2 is required for growth factor-stimulated transcription of the c-Fos gene Proc. Natl. Acad. Sci. USA 97 2000 2462-2467
4. J.C. Bruning M.D. Michael J.N. Winnay T. Hayashi D. Horsch D. Accili L.J. Goodyear C.R. Kahn A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance Mol. Cell 2 1998 559-569
5. H. Chi E. Messas R.A. Levine D.T. Graves S. Amar Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications Circulation 110 2004 1678-1685
6. B.E. Clausen C. Burkhardt W. Reith R. Renkawitz I. Forster Conditional gene targeting in macrophages and granulocytes using LysMcre mice Transgenic Res. 8 1999 265-277
7. M.H. Clough D.J. Schneider B.E. Sobel M.F. White M.P. Wadsworth D.J. Taatjes Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E J. Histochem. Cytochem. 53 2005 603-610
8. P. Dandona A. Aljada P. Mohanty H. Ghanim W. Hamouda E. Assian S. Ahmad Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect? J. Clin. Endocrinol. Metab. 86 2001 3257-3265
9. W. Dietrich H. Katz S.E. Lincoln H.S. Shin J. Friedman N.C. Dracopoli E.S. Lander A genetic map of the mouse suitable for typing intraspecific crosses Genetics 131 1992 423-447
10. W.F. Dietrich J. Miller R. Steen M.A. Merchant D. Damron-Boles Z. Husain R. Dredge M.J. Daly K.A. Ingalls T.J. O'Connor A comprehensive genetic map of the mouse genome Nature 380 1996 149-152
11. M.M. Engelgau L.S. Geiss J.B. Saaddine J.P. Boyle S.M. Benjamin E.W. Gregg E.F. Tierney N. Rios-Burrows A.H. Mokdad E.S. Ford et. al. The evolving diabetes burden in the United States Ann. Intern. Med. 140 2004 945-950
12. M.E. Hartman J.C. O'Connor J.P. Godbout K.D. Minor V.R. Mazzocco G.G. Freund Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus J. Biol. Chem. 279 2004 28045-28050
13. V. Holan J. Minowada Selective enhancement of interleukin 1 beta production in myelomonocytic cell lines by insulin and its related cytokines Immunol. Lett. 34 1992 243-247
14. S.A. Huber P. Sakkinen D. Conze N. Hardin R. Tracy Interleukin-6 exacerbates early atherosclerosis in mice Arterioscler. Thromb. Vasc. Biol. 19 1999 2364-2367
15. K.T. Iida H. Shimano Y. Kawakami H. Sone H. Toyoshima S. Suzuki T. Asano Y. Okuda N. Yamada Insulin up-regulates tumor necrosis factor-alpha production in macrophages through an extracellular-regulated kinase-dependent pathway J. Biol. Chem. 276 2001 32531-32537
16. C.M. Kelly I.G. Fantus Insulin binding in non-insulin-dependent diabetes mellitus (NIDDM) is correlated with glycemic control: Clinical evidence for abnormal receptor regulation in NIDDM Metabolism 44 1995 506-512
17. N. Kubota K. Tobe Y. Terauchi K. Eto T. Yamauchi R. Suzuki Y. Tsubamoto K. Komeda R. Nakano H. Miki et. al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia Diabetes 49 2000 1880-1889
18. T. Kubota N. Kubota M. Moroi Y. Terauchi T. Kobayashi K. Kamata R. Suzuki K. Tobe A. Namiki S. Aizawa et. al. Lack of insulin receptor substrate-2 causes progressive neointima formation in response to vessel injury Circulation 107 2003 3073-3080
19. C.P. Liang S. Han H. Okamoto R. Carnemolla I. Tabas D. Accili A.R. Tall Increased CD36 protein as a response to defective insulin signaling in macrophages J. Clin. Invest. 113 2004 764-773
20. P. Libby Inflammation in atherosclerosis Nature 420 2002 868-874
21. J.J. Luiken D.J. Dyck X.X. Han N.N. Tandon Y. Arumugam J.F. Glatz A. Bonen Insulin induces the translocation of the fatty acid transporter FAT/CD36 to the plasma membrane Am. J. Physiol. Endocrinol. Metab. 282 2002 E491-E495
22. L. Makowski J.B. Boord K. Maeda V.R. Babaev K.T. Uysal M.A. Morgan R.A. Parker J. Suttles S. Fazio G.S. Hotamisligil M.F. Linton Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis Nat. Med. 7 2001 699-705
23. K. Malmberg L. Ryden S. Efendic J. Herlitz P. Nicol A. Waldenstrom H. Wedel L. Welin Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year J. Am. Coll. Cardiol. 26 1995 57-65
24. L.J. Mandarino P.J. Campbell I.S. Gottesman J.E. Gerich Abnormal coupling of insulin receptor binding in noninsulin-dependent diabetes Am. J. Physiol. 247 1984 E688-E692
25. A. Mukhopadhyay J. Suttles R.D. Stout B.B. Aggarwal Genetic deletion of the tumor necrosis factor receptor p60 or p80 abrogates ligand-mediated activation of nuclear factor-kappa B and of mitogen-activated protein kinases in macrophages J. Biol. Chem. 276 2001 31906-31912
26. L. O'Rourke L.M. Gronning S.J. Yeaman P.R. Shepherd Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin J. Biol. Chem. 277 2002 42557-42562
27. M. Peitz K. Pfannkuche K. Rajewsky F. Edenhofer Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: A tool for efficient genetic engineering of mammalian genomes Proc. Natl. Acad. Sci. USA 99 2002 4489-4494
28. P. Reaven Metabolic syndrome J. Insur. Med. 36 2004 132-142
29. V. Trischitta A. Brunetti A. Chiavetta L. Benzi V. Papa R. Vigneri Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients Diabetes 38 1989 1579-1584
30. D. Vicent J. Ilany T. Kondo K. Naruse S.J. Fisher Y.Y. Kisanuki S. Bursell M. Yanagisawa G.L. King C.R. Kahn The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance J. Clin. Invest. 111 2003 1373-1380